Three things to know:
1. OCV Partners led the equity financings, with continued participation from Ortho Vision and Secocha Ventures, both existing investors.
2. Ossio has raised a total of $35 million to date. The company will use the proceeds for U.S. commercialization of its OSSIOfiber Intelligent Bone Regeneration Technology and operational expansion.
3. The OSSIOfiber technology uses a proprietary bio-integrative material designed to provide stability and maintain the alignment of bone fractures, osteotomies, arthrodesis and bone grafts during the healing process without permanent hardware.
More articles on devices:
21 spine devices receive FDA 510(k) clearance in February
FDA recorded 1.1M medical device-related injuries in internal reporting system — 4 things to know
SpineGuard granted patent for spinal ultrasound mapping technology — 3 insights
